Semaglutide GLP-1 is an active ingredient in Ozempic and Wegovy, both brand-name versions of semaglutide GLP-1 that bind to the glucagon-like peptide-1 (GLP-1) receptor
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Tirzepatide Peptide: Benefits, Uses, Side Effects, Dosage, and Research
If youre not losing weight in a calorie deficit, it may be due to underlying factors that make progress harder
Starting any new medication means being aware of how it might affect your body
A 2024 meta-analysis of 35 RCTs found selenium supplementation significantly reduced TPO antibodies, TSH, and oxidative stress markers in Hashimoto's patients - effects mediated through the GPx-glutathione system
Oral semaglutide titrated to 14 mg daily reduced 3-point MACE by 14% in SOUL (HR 0.86, 95% CI 0.770.96), with the principal driver a 26% reduction in nonfatal MI